Consensus on BCR‐ABL1 reporting in chronic myeloid leukaemia in the UK

For patients with chronic myeloid leukaemia (CML), treatment guidelines recommend monitoring response to treatment with tyrosine kinase inhibitors (TKIs) by testing the BCR‐ABL1 fusion gene transcript level using reverse transcriptase quantitative polymerase chain reaction. Despite recent efforts to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Haematol
Main Authors: Cross, Nicholas C. P., White, Helen E., Evans, Paul A. S., Hancock, Jeremy, Copland, Mhairi, Milojkovic, Dragana, Mason, Joanne, Craine, Sandra, Mead, Adam J.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Reviews
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6175193/
https://ncbi.nlm.nih.gov/pubmed/30125955
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.15542
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados